State Street Corp Roivant Sciences Ltd. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, State Street Corp holds 18,442,688 shares of ROIV stock, worth $215 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,442,688

Previous 17,153,134 7.52%

Holding current value

$215 Million

Previous $181 Million 7.82%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.36 - $11.74 $13.4 Million - $15.1 Million	1,289,554 Added 7.52%	18,442,688 $195 Million
Q1 2024 May 15, 2024	BUY	$9.87 - $11.8 $33.8 Million - $40.4 Million	3,425,716 Added 24.96%	17,153,134 $181 Million
Q4 2023 Feb 14, 2024	BUY	$8.38 - $11.58 $28.5 Million - $39.4 Million	3,406,626 Added 33.01%	13,727,418 $154 Million
Q3 2023 Nov 14, 2023	BUY	$9.76 - $13.19 $7.68 Million - $10.4 Million	786,896 Added 8.25%	10,320,792 $121 Million
Q2 2023 Aug 14, 2023	BUY	$7.09 - $10.08 $10.6 Million - $15.1 Million	1,500,944 Added 18.68%	9,533,896 $96.1 Million
Q1 2023 May 15, 2023	BUY	$6.92 - $9.98 $31.3 Million - $45.2 Million	4,525,910 Added 129.05%	8,032,952 $59.3 Million
Q4 2022 Feb 14, 2023	BUY	$3.36 - $7.99 $8.74 Million - $20.8 Million	2,601,911 Added 287.46%	3,507,042 $28 Million
Q3 2022 Nov 15, 2022	SELL	$0.51 - $4.84 $97,805 - $928,191	-191,775 Reduced 17.48%	905,131 $2.92 Million
Q2 2022 Aug 15, 2022	BUY	$2.81 - $4.84 $1.82 Million - $3.14 Million	649,000 Added 144.9%	1,096,906 $4.46 Million
Q1 2022 May 16, 2022	BUY	$4.74 - $9.91 $739,942 - $1.55 Million	156,106 Added 53.5%	447,906 $2.21 Million
Q4 2021 Feb 14, 2022	BUY	$5.86 - $13.52 $1.71 Million - $3.95 Million	291,800 New	291,800 $2.94 Million

Others Institutions Holding ROIV

# of Institutions

314

Shares Held

496M

Call Options Held

991K

Put Options Held

1.15M

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.23B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Roivant Sciences Ltd. Transaction History